Compare SkinBioTherapeutics Plc with Similar Stocks
Dashboard
1
Poor Management Efficiency with a low ROE of 0%
- The company has reported losses. Due to this company has reported negative ROE
2
Poor long term growth as Operating profit has grown by an annual rate 5.53% of over the last 5 years
3
With a growth in Net Sales of 94.2%, the company declared Very Positive results in Jun 25
4
Risky -
5
Below par performance in long term as well as near term
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-52.83%
0%
-52.83%
6 Months
-62.42%
0%
-62.42%
1 Year
-74.23%
0%
-74.23%
2 Years
-13.79%
0%
-13.79%
3 Years
-64.79%
0%
-64.79%
4 Years
-86.56%
0%
-86.56%
5 Years
-86.63%
0%
-86.63%
SkinBioTherapeutics Plc for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
41.34%
EBIT Growth (5y)
5.53%
EBIT to Interest (avg)
-2.92
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.05
Sales to Capital Employed (avg)
0.19
Tax Ratio
0.96%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.95
EV to EBIT
-21.16
EV to EBITDA
-23.77
EV to Capital Employed
4.44
EV to Sales
5.12
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-20.99%
ROE (Latest)
-12.70%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Jun'25
Jun'25
Jun'24
Change(%)
Net Sales
4.60
1.20
283.33%
Operating Profit (PBDIT) excl Other Income
-0.40
-2.40
83.33%
Interest
0.10
0.10
Exceptional Items
0.20
-0.30
166.67%
Consolidate Net Profit
-0.70
-2.90
75.86%
Operating Profit Margin (Excl OI)
-178.30%
-2,133.30%
195.50%
USD in Million.
Net Sales
YoY Growth in year ended Jun 2025 is 283.33% vs 1,100.00% in Jun 2024
Consolidated Net Profit
YoY Growth in year ended Jun 2025 is 75.86% vs -3.57% in Jun 2024
About SkinBioTherapeutics Plc 
SkinBioTherapeutics Plc
Pharmaceuticals & Biotechnology
SkinBioTherapeutics PLC is a life science company focused on skin health. The Company’s platform technology, SkinBiotix, applies research discoveries made on the activities of lysates derived from probiotic bacteria when applied to skin. The Company’s SkinBiotix platform can improve the barrier effect of skin models, improve repair and reduce bacterial load. It focuses on three specific skin healthcare sectors: cosmetics, infection control and eczema. In each of these areas, the Company plans to exemplify its technology in human studies. The Company’s program is focused on the application of the Skinbiotix platform in managing sensitive skin in the cosmetics industry. SkinBiotix increases the rate of skin healing in response to injury.
Company Coordinates 
Company Details
15 1 Silk House, Park Green , MACCLESFIELD None : SK11 7QJ
Registrar Details






